Status: Recruiting
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BSY001 After Single/Multiple Doses.
A Two-Phase, Randomized, Double-Blind, Placebo-Controlled Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BSY001 for Injection Following Single or Multiple Doses in Healthy Subjects
Participants needed: 76
Trial details
Phase: Phase 1Age: 18-50Biological sex: AllType: InterventionalSponsor: China National Biotec Group Company LimitedUpdated: Jan 29, 2026Locations: 1
Eligibility criteria
Subjects voluntarily participate in the study, sign the informed consent form, a... [+3]
Subjects with a known allergy to Tecovirimat drugs, any excipient ingredients in... [+22]